Skip to content
RDL Network logo
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study — Ellen Burgess (2022) | RDL Network